chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Mass
Clinical narrative: Small lump under the chin, maybe a quarter size; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Small lump under the chin, maybe a quarter size) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to aspirin (GP6 whatever)) and Food allergy (Allergy to tomatoes).    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MASS (Small lump under the chin, maybe a quarter size). At the time of the report, MASS (Small lump under the chin, maybe a quarter size) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient said small lump under the chin is like a ball, not painful, and not affecting the breathing or anything.  Treatment information was not provided.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness on the left arm) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PAIN IN EXTREMITY (Soreness on the left arm). At the time of the report, PAIN IN EXTREMITY (Soreness on the left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Musculoskeletal stiffness, Nausea
Clinical narrative: Neck is stiff; Upper back is stiff; No appetite; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Neck is stiff), MUSCULOSKELETAL STIFFNESS (Upper back is stiff), DECREASED APPETITE (No appetite), NAUSEA (Nausea) and FATIGUE (Fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 029L20A) for COVID-19 vaccination.     The patient's past medical history included Back surgery (9 screws in her back) in November 2019 and Acupuncture on 16-Feb-2001.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Neck is stiff), MUSCULOSKELETAL STIFFNESS (Upper back is stiff), DECREASED APPETITE (No appetite), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, MUSCULOSKELETAL STIFFNESS (Neck is stiff), MUSCULOSKELETAL STIFFNESS (Upper back is stiff) and FATIGUE (Fatigue) outcome was unknown and DECREASED APPETITE (No appetite) and NAUSEA (Nausea) had not resolved.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to US-MODERNATX, INC.-MOD-2021-071303 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071303:1st dose vaccine
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspepsia, Malaise, Nasopharyngitis, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (She experienced indigestion.), MALAISE (She felt sick.), NASOPHARYNGITIS (She experienced cold.), CHILLS (She experienced chills.) and VOMITING (She experienced vomiting.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DYSPEPSIA (She experienced indigestion.), MALAISE (She felt sick.), NASOPHARYNGITIS (She experienced cold.), CHILLS (She experienced chills.) and VOMITING (She experienced vomiting.). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) at a dose of 1 dosage form. At the time of the report, DYSPEPSIA (She experienced indigestion.), MALAISE (She felt sick.), NASOPHARYNGITIS (She experienced cold.), CHILLS (She experienced chills.) and VOMITING (She experienced vomiting.) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication were provided. Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Outcome of the events updated ( from not recovered to recovered)
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test positive
Clinical narrative: Pregnant patient reported received the vaccines on 25Feb2021 and 25March2021; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient reported received the vaccines on 25Feb2021 and 25March2021) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 047A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (social) on 06-Mar-2021. Concurrent medical conditions included Latex allergy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 30-Jan-2021 and the estimated date of delivery was 06-Nov-2021. On 25-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient reported received the vaccines on 25Feb2021 and 25March2021). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  third week of the pregnancy.  On 25-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient reported received the vaccines on 25Feb2021 and 25March2021) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Pregnancy test positive: positive positive.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Contusion, Muscle spasms, SARS-CoV-2 test, Skin discolouration
Clinical narrative: Cramps; Chills; Bruises change from red to dark blue; Bruises on my right leg; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruises on my right leg), MUSCLE SPASMS (Cramps), SKIN DISCOLOURATION (Bruises change from red to dark blue) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced CONTUSION (Bruises on my right leg). On 08-Apr-2021, the patient experienced SKIN DISCOLOURATION (Bruises change from red to dark blue). On an unknown date, the patient experienced MUSCLE SPASMS (Cramps) and CHILLS (Chills). At the time of the report, CONTUSION (Bruises on my right leg), MUSCLE SPASMS (Cramps), SKIN DISCOLOURATION (Bruises change from red to dark blue) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative. In 2021, Urine analysis: concentrated urine (abnormal) concentrated urine.         No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis
Clinical narrative: Cramps; Chills; Bruises change from red to dark blue; Bruises on my right leg; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruises on my right leg), MUSCLE SPASMS (Cramps), SKIN DISCOLOURATION (Bruises change from red to dark blue) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced CONTUSION (Bruises on my right leg). On 08-Apr-2021, the patient experienced SKIN DISCOLOURATION (Bruises change from red to dark blue). On an unknown date, the patient experienced MUSCLE SPASMS (Cramps) and CHILLS (Chills). At the time of the report, CONTUSION (Bruises on my right leg), MUSCLE SPASMS (Cramps), SKIN DISCOLOURATION (Bruises change from red to dark blue) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative. In 2021, Urine analysis: concentrated urine (abnormal) concentrated urine.         No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Erythema, Vaccination site discolouration
Clinical narrative: red/pinkish at injection site; weak; redness going down the arm; pinkish; Chills; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VACCINATION SITE DISCOLOURATION (red/pinkish at injection site), ASTHENIA (weak), ERYTHEMA (redness going down the arm) and VACCINATION SITE ERYTHEMA (pinkish) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD. Concomitant products included METOPROLOL, FUROSEMIDE (LASIX [FUROSEMIDE]), SIMVASTATIN, WARFARIN, LORAZEPAM, VITAMIN D3, VITAMIN C [ASCORBIC ACID] and FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (Dizziness), ERYTHEMA (redness going down the arm), VACCINATION SITE ERYTHEMA (pinkish) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (red/pinkish at injection site) and ASTHENIA (weak). At the time of the report, DIZZINESS (Dizziness) and ASTHENIA (weak) outcome was unknown, VACCINATION SITE DISCOLOURATION (red/pinkish at injection site) and VACCINATION SITE ERYTHEMA (pinkish) had not resolved, ERYTHEMA (redness going down the arm) was resolving and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. Treatment for the event was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-078550 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow up received on 15 Apr 2021 included information of concomitant medications-Warfarin, metoprolol, Lasix, lorazepam at night, simvastatin, vitamin D3, trilogy, vitamin C, first dose batch no.030A21A, events outcome.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-078550:First dose vaccination
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: red/pinkish at injection site; weak; redness going down the arm; pinkish; Chills; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VACCINATION SITE DISCOLOURATION (red/pinkish at injection site), ASTHENIA (weak), ERYTHEMA (redness going down the arm) and VACCINATION SITE ERYTHEMA (pinkish) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD. Concomitant products included METOPROLOL, FUROSEMIDE (LASIX [FUROSEMIDE]), SIMVASTATIN, WARFARIN, LORAZEPAM, VITAMIN D3, VITAMIN C [ASCORBIC ACID] and FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (Dizziness), ERYTHEMA (redness going down the arm), VACCINATION SITE ERYTHEMA (pinkish) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (red/pinkish at injection site) and ASTHENIA (weak). At the time of the report, DIZZINESS (Dizziness) and ASTHENIA (weak) outcome was unknown, VACCINATION SITE DISCOLOURATION (red/pinkish at injection site) and VACCINATION SITE ERYTHEMA (pinkish) had not resolved, ERYTHEMA (redness going down the arm) was resolving and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. Treatment for the event was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-078550 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow up received on 15 Apr 2021 included information of concomitant medications-Warfarin, metoprolol, Lasix, lorazepam at night, simvastatin, vitamin D3, trilogy, vitamin C, first dose batch no.030A21A, events outcome.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-078550:First dose vaccination
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling abnormal, Headache, Myalgia, Pain
Clinical narrative: Horrible crucial body pain; Felt like dying; Weakness; Squeezing muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Horrible crucial body pain), FEELING ABNORMAL (Felt like dying), ASTHENIA (Weakness), MYALGIA (Squeezing muscle pain) and HEADACHE (Headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017A21A and 030A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PAIN (Horrible crucial body pain), FEELING ABNORMAL (Felt like dying), ASTHENIA (Weakness), MYALGIA (Squeezing muscle pain) and HEADACHE (Headache). On 08-Apr-2021, PAIN (Horrible crucial body pain) and FEELING ABNORMAL (Felt like dying) had resolved. At the time of the report, ASTHENIA (Weakness), MYALGIA (Squeezing muscle pain) and HEADACHE (Headache) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-071330 (E2B Linked Report).; Sender's Comments:  MOD-2021-071330:First  dose case
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching). At the time of the report, PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. Treatment medication not provided.   This case was linked to MOD-2021-071350 (E2B Linked Report).; Sender's Comments:  MOD-2021-071350:2nd dose case
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Swelling
Clinical narrative: pain in the arm; swelling; aching all over; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), SWELLING (swelling) and PAIN (aching all over) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm), SWELLING (swelling) and PAIN (aching all over). At the time of the report, PAIN IN EXTREMITY (pain in the arm), SWELLING (swelling) and PAIN (aching all over) outcome was unknown.            This case was linked to MOD-2021-071345 (E2B Linked Report).; Sender's Comments:  MOD-2021-071345:1st dose case
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Tooth disorder, Vaccination site pain
Clinical narrative: Tooth pocket that appeared/it is painful and twinging, ( discomfort) "flinges" and throbbing; Hurt a bit; Arm was hurting more; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH DISORDER (Tooth pocket that appeared/it is painful and twinging, ( discomfort) "flinges" and throbbing), PAIN (Hurt a bit) and VACCINATION SITE PAIN (Arm was hurting more) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (esophageal), Gastritis and Root canal procedure. Previously administered products included for Product used for unknown indication: Flu vaccine, Flu vaccine and Flu vaccine. Past adverse reactions to the above products included Burn with Flu vaccine; Numbness with Flu vaccine; and Pain with Flu vaccine. Concurrent medical conditions included Hypertension and Fibromyalgia. Concomitant products included AMLODIPINE for Heart disorder.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced TOOTH DISORDER (Tooth pocket that appeared/it is painful and twinging, ( discomfort) "flinges" and throbbing), PAIN (Hurt a bit) and VACCINATION SITE PAIN (Arm was hurting more). On 15-Mar-2021, TOOTH DISORDER (Tooth pocket that appeared/it is painful and twinging, ( discomfort) "flinges" and throbbing), PAIN (Hurt a bit) and VACCINATION SITE PAIN (Arm was hurting more) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include beta blocker for heart condition. No treatment information was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Somnolence, Vaccination site nodule
Clinical narrative: Very Sleepy; Upset stomach; Knot on the Injection Site (Nickle Size); This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Very Sleepy), ABDOMINAL DISCOMFORT (Upset stomach) and VACCINATION SITE NODULE (Knot on the Injection Site (Nickle Size)) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE NODULE (Knot on the Injection Site (Nickle Size)). On 20-Mar-2021, the patient experienced SOMNOLENCE (Very Sleepy) and ABDOMINAL DISCOMFORT (Upset stomach). On 21-Mar-2021, SOMNOLENCE (Very Sleepy) and ABDOMINAL DISCOMFORT (Upset stomach) had resolved. On 25-Mar-2021, VACCINATION SITE NODULE (Knot on the Injection Site (Nickle Size)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. .   This case was linked to US-MODERNATX, INC.-MOD-2021-071983 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071983:
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine received at 23rd day of 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. On 08-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION had resolved. Not Provided.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product used was not provided by the reporter.     Reporter did not allow further contact.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives all over the body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives all over the body) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced URTICARIA (Hives all over the body). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of UNK, bid. At the time of the report, URTICARIA (Hives all over the body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer and describes the occurrence of hyperhidrosis (woke up in sweats), pain in extremity (sore arm), chills, pyrexia (fever) and fatigue in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 019B21A) for COVID-19 immunization. No medical history reported. On Apr 5, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 5, 2021, patient experienced pain in extremity (sore arm), chills, pyrexia (fever) and fatigue. On Apr 6, 2021, patient experienced hyperhidrosis (woke up in sweats). At the time of the report, hyperhidrosis (woke up in sweats), pain in extremity (sore arm), chills, pyrexia (fever) and fatigue outcome: unknown. The action taken: not applicable. The patient had already taken the second dose of vaccine. Concomitant drugs not provided. This case linked to MOD21-050937 (patient link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Vomiting
Clinical narrative: Vomiting; Chills; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced VOMITING (Vomiting), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue). On 18-Mar-2021, VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, FATIGUE (Fatigue) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Muscle tightness
Clinical narrative: Felt extremely dizzy, never felt dizzy before; Muscles of back were tight; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt extremely dizzy, never felt dizzy before) and MUSCLE TIGHTNESS (Muscles of back were tight) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced DIZZINESS (Felt extremely dizzy, never felt dizzy before) and MUSCLE TIGHTNESS (Muscles of back were tight). At the time of the report, DIZZINESS (Felt extremely dizzy, never felt dizzy before) and MUSCLE TIGHTNESS (Muscles of back were tight) had not resolved. Not provided. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Heart rate
Clinical narrative: Tired; Feeling funny; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL and FATIGUE in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included AFib.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced FEELING ABNORMAL. On 07-Apr-2021, the patient experienced FATIGUE. The patient was treated with METOPROLOL ongoing since an unknown date at a dose of UNK. On 08-Apr-2021, FEELING ABNORMAL and FATIGUE had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Heart rate: 128 beats per minute (High). On 08-Apr-2021, Heart rate: normal per minute (normal).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       Concomitant medications included heart medications.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Body aches after 1st dose; Fatigue after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches after 1st dose) and FATIGUE (Fatigue after 1st dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014m20a and 008b212a) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction (Rag weed) and Anaphylactic reaction (Bees).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches after 1st dose) and FATIGUE (Fatigue after 1st dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN (Body aches after 1st dose) and FATIGUE (Fatigue after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.     This case was linked to MODERNATX, INC.-MOD-2021-071381 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-071381:Second dose case
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Pharyngeal swelling, Swollen tongue, Throat irritation
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Tickle in her throat), SWOLLEN TONGUE (Tongue and throat swelling), PHARYNGEAL SWELLING (Tongue and throat swelling) and ALLERGY TO VACCINE (Allergic reaction) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy, Drug allergy, Drug allergy and Drug allergy. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (Tickle in her throat), SWOLLEN TONGUE (Tongue and throat swelling), PHARYNGEAL SWELLING (Tongue and throat swelling) and ALLERGY TO VACCINE (Allergic reaction). At the time of the report, THROAT IRRITATION (Tickle in her throat), SWOLLEN TONGUE (Tongue and throat swelling), PHARYNGEAL SWELLING (Tongue and throat swelling) and ALLERGY TO VACCINE (Allergic reaction) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided. No treatment information provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hyperhidrosis, Paraesthesia oral
Clinical narrative: Warm surge through the body; Broke out in sweat; Tingling in tongue; Tingling of upper lip; Tip of tongue felt funny; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm surge through the body), HYPERHIDROSIS (Broke out in sweat), PARAESTHESIA ORAL (Tingling in tongue), PARAESTHESIA ORAL (Tingling of upper lip) and PARAESTHESIA ORAL (Tip of tongue felt funny) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Warm surge through the body), HYPERHIDROSIS (Broke out in sweat), PARAESTHESIA ORAL (Tingling in tongue), PARAESTHESIA ORAL (Tingling of upper lip) and PARAESTHESIA ORAL (Tip of tongue felt funny). At the time of the report, FEELING HOT (Warm surge through the body), HYPERHIDROSIS (Broke out in sweat), PARAESTHESIA ORAL (Tingling in tongue), PARAESTHESIA ORAL (Tingling of upper lip) and PARAESTHESIA ORAL (Tip of tongue felt funny) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Cough, Dyspnoea, Fatigue, Hypersensitivity
Clinical narrative: Was up all night again; Asthma; Allergies which is worse this year; Nasal congestion; Coughing; Shortness of breath; Runny stuffed up nose; Cannot sleep all night; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Was up all night again), ASTHMA (Asthma), HYPERSENSITIVITY (Allergies which is worse this year), NASAL CONGESTION (Nasal congestion) and COUGH (Coughing) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SLEEP DISORDER (Was up all night again), ASTHMA (Asthma), HYPERSENSITIVITY (Allergies which is worse this year), NASAL CONGESTION (Nasal congestion), COUGH (Coughing), DYSPNOEA (Shortness of breath), RHINORRHOEA (Runny stuffed up nose), SLEEP DISORDER (Cannot sleep all night) and FATIGUE (Fatigue). At the time of the report, SLEEP DISORDER (Was up all night again), ASTHMA (Asthma), HYPERSENSITIVITY (Allergies which is worse this year), NASAL CONGESTION (Nasal congestion), COUGH (Coughing), DYSPNOEA (Shortness of breath), RHINORRHOEA (Runny stuffed up nose), SLEEP DISORDER (Cannot sleep all night) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment for the event include Inhaler, allergy medications.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Rhinorrhoea, Sleep disorder
Clinical narrative: Was up all night again; Asthma; Allergies which is worse this year; Nasal congestion; Coughing; Shortness of breath; Runny stuffed up nose; Cannot sleep all night; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Was up all night again), ASTHMA (Asthma), HYPERSENSITIVITY (Allergies which is worse this year), NASAL CONGESTION (Nasal congestion) and COUGH (Coughing) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SLEEP DISORDER (Was up all night again), ASTHMA (Asthma), HYPERSENSITIVITY (Allergies which is worse this year), NASAL CONGESTION (Nasal congestion), COUGH (Coughing), DYSPNOEA (Shortness of breath), RHINORRHOEA (Runny stuffed up nose), SLEEP DISORDER (Cannot sleep all night) and FATIGUE (Fatigue). At the time of the report, SLEEP DISORDER (Was up all night again), ASTHMA (Asthma), HYPERSENSITIVITY (Allergies which is worse this year), NASAL CONGESTION (Nasal congestion), COUGH (Coughing), DYSPNOEA (Shortness of breath), RHINORRHOEA (Runny stuffed up nose), SLEEP DISORDER (Cannot sleep all night) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment for the event include Inhaler, allergy medications.
Sex: F
Vaccine: COVID19
Symptoms: Tooth fracture
Clinical narrative: cracked tooth; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH FRACTURE (cracked tooth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TOOTH FRACTURE (cracked tooth). At the time of the report, TOOTH FRACTURE (cracked tooth) outcome was unknown.            Patient wanted to know whether it was ok to take steroid pack for the event or was it true that she should wait for 14 days.The action taken was assessed as not applicable since the patient had already taken the second dose of the vaccine. No concomitant drugs were provided.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dyschromatopsia, Ear pain, Fibromyalgia, Influenza like illness
Clinical narrative: Fibro myalgia; Felt like he has had the flu; Severe earache; Right after, about 4-5minutes after receiving the vaccine, the paper he was holding started glowing and enhanced the colors of the paper which lasted about 90 seconds; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Severe earache), DYSCHROMATOPSIA (Right after, about 4-5minutes after receiving the vaccine, the paper he was holding started glowing and enhanced the colors of the paper which lasted about 90 seconds), FIBROMYALGIA (Fibro myalgia) and INFLUENZA LIKE ILLNESS (Felt like he has had the flu) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced EAR PAIN (Severe earache) and DYSCHROMATOPSIA (Right after, about 4-5minutes after receiving the vaccine, the paper he was holding started glowing and enhanced the colors of the paper which lasted about 90 seconds). On an unknown date, the patient experienced FIBROMYALGIA (Fibro myalgia) and INFLUENZA LIKE ILLNESS (Felt like he has had the flu). The patient was treated with KRATOM for Acute pain, at an unspecified dose and frequency and LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. On 07-Apr-2021, DYSCHROMATOPSIA (Right after, about 4-5minutes after receiving the vaccine, the paper he was holding started glowing and enhanced the colors of the paper which lasted about 90 seconds) outcome was unknown. At the time of the report, EAR PAIN (Severe earache), FIBROMYALGIA (Fibro myalgia) and INFLUENZA LIKE ILLNESS (Felt like he has had the flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pruritus
Clinical narrative: Did not get second dose/been around 45 days; Bad itching all over the body around 24 hours after getting first shot; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not get second dose/been around 45 days) and PRURITUS (Bad itching all over the body around 24 hours after getting first shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not get second dose/been around 45 days) and PRURITUS (Bad itching all over the body around 24 hours after getting first shot). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not get second dose/been around 45 days) had resolved and PRURITUS (Bad itching all over the body around 24 hours after getting first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  Treatment information was not provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Inappropriate schedule of vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 08-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to US-MODERNATX, INC.-MOD-2021-071157 (E2B Linked Report); Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071157:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Myalgia
Clinical narrative: Neuropathy in right hand has increased; persistent right muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Neuropathy in right hand has increased) and MYALGIA (persistent right muscle pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 013A21A) for COVID-19 vaccination.     The patient's past medical history included Shoulder replacement in June 2018, Colon cancer in August 2018 and Radiation exposure in January 2019. Concurrent medical conditions included Neuropathy (Neuropathy in right hand has increased) since June 2018.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced HYPOAESTHESIA (Neuropathy in right hand has increased) and MYALGIA (persistent right muscle pain). At the time of the report, HYPOAESTHESIA (Neuropathy in right hand has increased) and MYALGIA (persistent right muscle pain) outcome was unknown.            No concomitant medication and treatment medication were provided.   This case was linked to MOD-2021-074793 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Non-Significant follow up information was added: Contact information updated, Address of reporter updated.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Discomfort
Clinical narrative: prueba para covid-19 positiva/ tested positive for COVID-19; felt discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT felt discomfort) and COVID-19 (COVID-19 tested positive for COVID-19) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced DISCOMFORT ( felt discomfort). On 02-Apr-2021, the patient experienced COVID-19 (COVID-19 tested positive for COVID-19). At the time of the report, DISCOMFORT (sintió malestar/ felt discomfort) and COVID-19 (COVID-19 tested positive for COVID-19) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications involve acetaminophen, ivermectin, naproxen, vitamins C and A, zinc. No concomitant medications reported. The patient, received the first dose of the Moderna vaccine on 25Mar2021 and on Thursday 01Apr2021 he felt discomfort, so on 02Apr2021 he had a test for covid-19 and it was positive. The caller wants to know if the patient will be able to receive the second dose on 30 April 2021.